People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)
A recent letter published in the journal Science aims to jump-start conversations on the importance of inclusive language in the sciences as
As weary Americans hold out hope that the decline of Omicron signals an end to the pandemic’s emergency phase, physicians who treat
Some physicians are far more likely to deliver appropriate care than others in the same geographic area or health care system, according
Two treatments that have been shown to be ineffective against COVID-19 — hydroxychloroquine and ivermectin — were more heavily prescribed in the
Masks are coming off, mandates are easing, and people are beginning to mingle more freely. Spring is just around the corner. Despite the
A new cohort study of older adults finds excessive daytime napping may signal an elevated risk of Alzheimer’s disease. Investigators from Brigham and
Obtaining a medical marijuana card may pose a risk for those who use cannabis products to treat pain, anxiety, or depression, according
As a neurologist working in the COVID Survivorship Program at Beth Israel Deaconess Medical Center, I find that my patients all have
